021-51111890
购物车（0）
sales@molnova.cn
SXC 2023
CAS No. 1695562-36-7
SXC 2023 ( —— )
产品货号. M36974 CAS No. 1695562-36-7
SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥315 | 有现货 |
|
| 10MG | ￥460 | 有现货 |
|
| 25MG | ￥735 | 有现货 |
|
| 50MG | ￥1181 | 有现货 |
|
| 100MG | ￥1935 | 有现货 |
|
| 500MG | ￥4835 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称SXC 2023
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.
-
产品描述SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number1695562-36-7
-
分子量281.33
-
分子式C13H15NO4S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(SC[C@H](NC(C)=O)C(O)=O)(=O)C1=CC=C(C)C=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
dl-Ibuterol hydrochl...
dl-Ibuterol hydrochloride (Ibuterol HCl) has vasodilatory activity and can be used to study asthma and bronchospasm.
-
Gefapixant citrate
Gefapixant citrate 是一个口服有效的 P2X3 受体 (P2X3R) 拮抗剂，其对人同源重组 hP2X3 和 hP2X2/3 的 IC50 值分别是 ~30 nM 和 100-250 nM。Gefapixant citrate 可用于慢性咳嗽与膝骨关节炎的研究。
-
Harmol
Harmol 是从自然界中分离出来的 β-咔啉。
